Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kanghuai Medical is a high-tech medical device company specializing in the application of 3D printing technology for personalized orthopedic solutions. Founded in 2016 and headquartered in Changzhou, China, the company develops and manufactures a range of 3D-printed titanium alloy implants, including interbody fusion cages, artificial vertebral bodies, and acetabular cups. Their platform integrates medical imaging, digital surgical planning, and additive manufacturing to provide patient-specific implants and surgical guides. Kanghuai Medical has successfully obtained multiple NMPA (National Medical Products Administration) clearances for its products, positioning itself as a leader in the digital orthopedics market in China. The company's services extend to providing customized skull repair systems and trauma fixation solutions, significantly improving surgical precision and patient outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kanghuai.